Diebold Nixdorf, IncorporatedDBDNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank21
3Y CAGR-10.5%
5Y CAGR-8.3%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-10.5%/yr
vs -6.4%/yr prior
5Y CAGR
-8.3%/yr
Consistent
Acceleration
-4.1pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
7 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$86.40M-7.7%
2024$93.60M-15.6%
2023$110.90M-8.1%
2022$120.70M-4.4%
2021$126.30M-5.3%
2020$133.40M-7.4%
2019$144.10M-8.4%
2018$157.40M+0.5%
2017$156.60M+49.0%
2016$105.10M-